# Black Cumin Seed Sleep Quality Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/black-cumin-seed-sleep-quality-randomized-trial-evidence-review
Category: evidence-review
Summary: Black Cumin Seed Sleep Quality Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first 
Last reviewed: 2026-08-05
Reviewed by: Migaku Evidence Review
# Black Cumin Seed Sleep Quality Randomized Trial: What the Evidence Says

## Quick Answer

Black Cumin Seed Sleep Quality Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Non-Pharmacological Complementary and Alternative Therapies for Knee Osteoarthritis: A Scoping Review of Randomized Controlled Trials | randomized trial | 2 | 2026-06-20 | 10.2147/JPR.S608480 |
| The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs | narrative review | 3 | 2025-09-19 | 10.3390/molecules30183814 |

## What The Sources Report

- A scoping review is therefore appropriate when the objective is not to pool effects, but to map the range of available RCT evidence, clarify how interventions have been conceptualized and studied, and identify evidence gaps that can guide future systematic reviews and pragmatic trials. [Kang Yanhong (2026); evidence level 2]
- The objective of this scoping review was to map RCT evidence on non-pharmacological CAM and related integrative interventions for adults with KOA. [Kang Yanhong (2026); evidence level 2]
- These disturbances occur despite adequate opportunity and conditions for sleep, and they result in general dissatisfaction with sleep quality and various daytime impairments. [Żełabowski Kacper (2025); evidence level 3]
- Individuals reporting nighttime symptoms without associated daytime dysfunction are not classified as having clinical insomnia. [Żełabowski Kacper (2025); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For black cumin seed sleep quality randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Kang Yanhong (2026). Non-Pharmacological Complementary and Alternative Therapies for Knee Osteoarthritis: A Scoping Review of Randomized Controlled Trials. DOI: 10.2147/JPR.S608480. PMCID: PMC13295002. PMID: 42369078. License: https://creativecommons.org/licenses/by-nc/4.0/ https://www.dovepress.com/terms.php http://creativecommons.org/licens.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13295002/
- Żełabowski Kacper (2025). The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs. DOI: 10.3390/molecules30183814. PMCID: PMC12472680. PMID: 41011705. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12472680/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.